DR. ALEXANDER GRINBERG, M.D.
Psychiatric at Sutter St, San Francisco, CA
License number
California A56467
Category
Psychiatric
Type
Psychiatry
Address
Address
2320 Sutter St SUITE 101, San Francisco, CA 94115
Phone
(415) 876-0475
Personal information
See more information about ALEXANDER GRINBERG at radaris.comName
Address
Phone
600 15Th Ave, San Francisco, CA 94118
2320 Sutter St, San Francisco, CA 94115
600 15Th Ave, San Francisco, CA 94118
2328 Sutter St, San Francisco, CA 94115
San Francisco, CA
Organization information
See more information about ALEXANDER GRINBERG at bizstanding.comAlexander Grinberg, MD
2320 Sutter St, San Francisco, CA 94115
Industry:
Psychiatrist
Registration:
Mar 1, 2000
Site:
Phone:
(415) 771-0700 (Phone), (415) 928-1311 (Fax)
M.D.:
Alexander Grinberg (M.D.)
Categories:
Psychiatrists & Psychiatric Services, Health & Medical - General
GMD Biological Advance - Alexander Grinberg MD
2320 Sutter St STE 101, San Francisco, CA 94115
Categories:
Physical Therapists, Psychiatry Physicians, Psychotherapists
Phone:
(415) 771-0700 (Phone)
Professional information
See more information about ALEXANDER GRINBERG at trustoria.com
President At Gmd
President At Gmd
Position:
president at GMD
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
GMD
-
president
Dr. Alexander Grinberg, San Francisco CA - MD (Doctor of Medicine)
Dr. Alexander Grinberg, San Francisco CA - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Psychiatry)
Address:
Alexander Grinberg MD
2320 Sutter St SUITE 101, San Francisco 94115
(415) 876-0475 (Phone)
2320 Sutter St SUITE 101, San Francisco 94115
(415) 876-0475 (Phone)
Certifications:
Psychiatry, 2001
Awards:
Healthgrades Honor Roll
Languages:
English, Russian
Hospitals:
Alexander Grinberg MD
2320 Sutter St SUITE 101, San Francisco 94115
UCSF Medical Center at Mount Zion
1600 Divisadero St, San Francisco 94115
2320 Sutter St SUITE 101, San Francisco 94115
UCSF Medical Center at Mount Zion
1600 Divisadero St, San Francisco 94115
Education:
Medical School
Taskent Medical Institute
Mt Sinai Med Center
Graduated: 1995
Creedmoore Psyc Center
Graduated: 1998
Taskent Medical Institute
Mt Sinai Med Center
Graduated: 1995
Creedmoore Psyc Center
Graduated: 1998
Nano- And Micro- Encapsulation Of Biomaterials Into Particles And Capsules By Varying Precipitation Conditions
Nano- And Micro- Encapsulation Of Biomaterials Into Particles And Capsules By Varying Precipitation Conditions
US Patent:
2012009, Apr 19, 2012
Filed:
Oct 13, 2011
Appl. No.:
13/272874
Inventors:
Alexander Grinberg - San Francisco CA, US
Andre Skirtach - Potsdam, DE
Dmitry V. Volodkin - Potsdam, DE
Helmuth Möhwald - Potsdam, DE
Stephan Schmidt - Potsdam, DE
Regine von Klitzing - Berlin, DE
Andre Skirtach - Potsdam, DE
Dmitry V. Volodkin - Potsdam, DE
Helmuth Möhwald - Potsdam, DE
Stephan Schmidt - Potsdam, DE
Regine von Klitzing - Berlin, DE
International Classification:
A61K 9/16, C07K 14/62, C07K 1/00
US Classification:
427 214, 530402, 530303
Abstract:
This invention describes novel methods for fabricating nano/micro particles and capsules through template decomposition which incorporates the to-be-encapsulated molecules which are precipitated in pores of particles or in solution, i.e. below their isoelectric point, drying or by solvent adjustment methods. The encapsulation process can be followed by a deposition or adsorption of a protective shell that regulates release of the encapsulated material. The encapsulation, inclusion, manipulation, and release of various materials and bio-materials is to be conducted by delivery vehicles which are particles and capsules with sizes in the range of nanometers and micrometers. They can possess multicompartment and anisotropic geometries and can carry one or several types of various molecules. This invention can potentially be used for controlled delivery, manipulation, and release in a variety of applications requiring delivery vehicles such as cell cultures, in-vivo, subcutaneous incorporation, injection, spray-inhalation and planar surfaces, films, and stents.
Nanoencapsulation And Release Of Nucleic Acids
Nanoencapsulation And Release Of Nucleic Acids
US Patent:
2009025, Oct 8, 2009
Filed:
Apr 4, 2009
Appl. No.:
12/418590
Inventors:
Alexander Grinberg - San Francisco CA, US
International Classification:
C07H 21/04
US Classification:
536 231
Abstract:
A method for Encapsulation of nucleic acids such as DNA, RNA any other types of nucleotides via entrapping or co-precipitation in CaCO3 porous microparticles followed by polymeric shell deposition or polymer nanoparticles composite shell deposition. This method can be used for controlled delivery and release of nucleic acids.
Application Of Nanotechnology For Blood Flow Meters
Application Of Nanotechnology For Blood Flow Meters
US Patent:
2009028, Nov 12, 2009
Filed:
May 12, 2009
Appl. No.:
12/464644
Inventors:
Alexander Grinberg - San Francisco CA, US
International Classification:
A61B 5/02
US Classification:
600504, 977904
Abstract:
Conventional blood flow meter can be combined with photonic crystals to measure temperature change for heat washin/washout. These photonic crystals are impregnated into conventional devices as a thermometer. It makes the entire device more compact and easier for patients.
Nano-, Micro-, Macro- Encapsulation And Release Of Materials
Nano-, Micro-, Macro- Encapsulation And Release Of Materials
US Patent:
2011017, Jul 21, 2011
Filed:
Jan 16, 2010
Appl. No.:
12/688879
Inventors:
Alexander Grinberg - San Francisco CA, US
International Classification:
B05D 7/00
US Classification:
427 214, 427212
Abstract:
This invention relates to nano-, micro-, and macro-encapsulation methods and constructs, including single and multi-compartment particles and capsules, and methods of release.
Nanoencapsulation Of Proteins
Nanoencapsulation Of Proteins
US Patent:
2009010, Apr 23, 2009
Filed:
Nov 23, 2006
Appl. No.:
11/563012
Inventors:
ALEXANDER GRINBERG - SAN FRANCISCO CA, US
International Classification:
A61K 9/14, C07K 14/62, A61K 38/28
US Classification:
424497, 530304, 514 3
Abstract:
The protein encapsulation via entrapping protein in CaCOmicroparticles followed by polymeric shell deposition can be used for vaccination based on protein antigen, and in particular rPA 102.